GMRE RSI Chart
Last 7 days
-4.7%
Last 30 days
-13.0%
Last 90 days
-27.6%
Trailing 12 Months
-5.1%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 141.6M | 144.3M | 144.4M | 141.0M |
2022 | 120.5M | 125.9M | 131.3M | 137.3M |
2021 | 99.4M | 105.6M | 110.5M | 115.9M |
2020 | 77.2M | 82.4M | 89.3M | 93.7M |
2019 | 56.8M | 60.5M | 64.7M | 70.7M |
2018 | 37.3M | 43.1M | 48.7M | 53.2M |
2017 | 11.6M | 17.2M | 23.6M | 30.3M |
2016 | 2.9M | 4.2M | 5.7M | 8.2M |
2015 | 1.9M | 2.0M | 2.0M | 2.1M |
2014 | 0 | 0 | 380.4K | 1.1M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Jan 30, 2023 | moore roscoe m jr | acquired | - | - | 7,412 | - |
Jan 10, 2023 | moore roscoe m jr | sold | -48,956 | 9.7913 | -5,000 | - |
Mar 29, 2022 | moore roscoe m jr | acquired | - | - | 5,000 | - |
Mar 04, 2022 | cole henry | bought | 19,999 | 15.5396 | 1,287 | - |
Mar 03, 2022 | busch jeffrey | bought | 31,100 | 15.55 | 2,000 | chairman, president and ceo |
Aug 19, 2021 | busch jeffrey | bought | 15,010 | 15.01 | 1,000 | chairman, president and ceo |
Mar 08, 2021 | busch jeffrey | bought | 24,167 | 13.81 | 1,750 | chairman, president and ceo |
Aug 12, 2020 | marston ronald | bought | 26,600 | 13.3 | 2,000 | - |
Aug 07, 2020 | busch jeffrey | bought | 133,900 | 13.39 | 10,000 | chairman, president and ceo |
Mar 12, 2020 | cole henry | bought | 19,978 | 10.8581 | 1,840 | - |
Which funds bought or sold GMRE recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Mar 22, 2024 | PNC FINANCIAL SERVICES GROUP, INC. | unchanged | - | 11,274 | 58,752 | -% |
Mar 15, 2024 | B. Riley Wealth Advisors, Inc. | reduced | -23.66 | -46,519 | 735,344 | 0.02% |
Mar 11, 2024 | VANGUARD GROUP INC | added | 1.27 | 13,762,900 | 68,122,200 | -% |
Mar 01, 2024 | Creekmur Asset Management LLC | new | - | 91,857 | 91,857 | 0.03% |
Mar 01, 2024 | GOLDMAN SACHS GROUP INC | added | 63.8 | 2,382,160 | 4,701,830 | -% |
Feb 28, 2024 | AMERICAN INTERNATIONAL GROUP, INC. | reduced | -0.4 | 63,500 | 336,663 | -% |
Feb 22, 2024 | AUXIER ASSET MANAGEMENT | sold off | -100 | -107,640 | - | -% |
Feb 20, 2024 | Quarry LP | sold off | -100 | -14,827 | - | -% |
Feb 16, 2024 | HARBOUR INVESTMENTS, INC. | unchanged | - | 1,917 | 9,990 | -% |
Feb 16, 2024 | PRICE T ROWE ASSOCIATES INC /MD/ | added | 6.59 | 40,000 | 164,000 | -% |
Unveiling Global Medical REIT Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Global Medical REIT Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
AMT | 92.0B | 11.1B | 67.33 | 8.26 | ||||
CCI | 45.8B | 7.0B | 30.53 | 6.57 | ||||
AVB | 26.1B | 2.8B | 28.1 | 9.43 | ||||
ARE | 21.9B | 2.9B | 211.79 | 7.61 | ||||
AMH | 13.1B | 1.6B | 30.39 | 8.17 | ||||
REG | 11.1B | 1.3B | 30.46 | 8.4 | ||||
BXP | 9.9B | 3.3B | 52.15 | 3.03 | ||||
MID-CAP | ||||||||
FRT | 8.4B | 1.1B | 35.55 | 7.44 | ||||
MAC | 3.7B | 884.1M | -13.45 | 4.17 | ||||
SLG | 3.5B | 899.4M | -6.17 | 3.87 | ||||
SMALL-CAP | ||||||||
AAT | 1.3B | 441.2M | 20.37 | 2.99 | ||||
AIV | 1.2B | 198.2M | -7.47 | 5.93 | ||||
MFA | 1.1B | 605.6M | 14.31 | 1.89 | ||||
NYMT | 650.5M | 258.7M | -13.37 | 2.51 | ||||
IVR | 461.8M | 277.9M | -29.12 | 1.66 |
Global Medical REIT Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Revenue | -7.2% | 33.00 | 36.00 | 36.00 | 36.00 | 36.00 | 35.00 | 34.00 | 32.00 | 30.00 | 30.00 | 28.00 | 27.00 | 25.00 | 25.00 | 22.00 | 22.00 | 20.00 | 18.00 | 17.00 | 15.00 | 14.00 |
Operating Expenses | -4.3% | 32.00 | 33.00 | 35.00 | 35.00 | 34.00 | 32.00 | 30.00 | 28.00 | 26.00 | 25.00 | 24.00 | 24.00 | 22.00 | 35.00 | 20.00 | 19.00 | 18.00 | 16.00 | 14.00 | 13.00 | 13.00 |
S&GA Expenses | -3.4% | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 1.00 |
Interest Expenses | -2.6% | 7.00 | 7.00 | 8.00 | 8.00 | 8.00 | 7.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 4.00 | 4.00 | 5.00 | 5.00 | 4.00 | 4.00 | 4.00 |
Net Income | -88.6% | 1.00 | 5.00 | 14.00 | 2.00 | 2.00 | 10.00 | 4.00 | 4.00 | 5.00 | 5.00 | 4.00 | 3.00 | 3.00 | -9.58 | 2.00 | 3.00 | 3.00 | 2.00 | 2.00 | 2.00 | 10.00 |
Net Income Margin | -3.4% | 0.15* | 0.16* | 0.20* | 0.13* | 0.15* | 0.18* | 0.15* | 0.16* | 0.16* | 0.14* | 0.00* | -0.02* | - | - | - | - | - | - | - | - | - |
Free Cashflow | 8.8% | 18.00 | 17.00 | 18.00 | 16.00 | 18.00 | 18.00 | 23.00 | 16.00 | 17.00 | 19.00 | 18.00 | 15.00 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Assets | -2.7% | 1,268 | 1,303 | 1,321 | 1,369 | 1,393 | 1,407 | 1,357 | 1,285 | 1,263 | 1,243 | 1,200 | 1,136 | 1,101 | 1,026 | 967 | 956 | 885 | 812 | 751 | 657 | 636 |
Cash Equivalents | -0.2% | 1.00 | 1.00 | 2.00 | 5.00 | 4.00 | 3.00 | 6.00 | 2.00 | 13.00 | 6.00 | 6.00 | 5.00 | 11.00 | 2.00 | 8.00 | 11.00 | 7.00 | 3.00 | 3.00 | 3.00 | 5.00 |
Goodwill | 0% | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | - | - | - | - | - | - |
Liabilities | -1.0% | 662 | 669 | 679 | 741 | 744 | 742 | 708 | 633 | 626 | 613 | 563 | 540 | 643 | 576 | 524 | 517 | 425 | 441 | 389 | 286 | 336 |
Shareholder's Equity | -4.6% | 584 | 611 | 641 | 628 | 633 | 665 | 649 | 653 | 638 | 630 | 637 | 596 | 458 | 449 | 443 | 439 | 460 | 371 | 362 | 371 | 300 |
Retained Earnings | -6.5% | -238 | -224 | -213 | -211 | -198 | -185 | -179 | -168 | -157 | -147 | -138 | -127 | -116 | -107 | -88.04 | -78.99 | -71.39 | -63.85 | -57.40 | -51.39 | -45.01 |
Additional Paid-In Capital | 0% | 722 | 722 | 722 | 722 | 722 | 722 | 722 | 720 | 711 | 700 | 700 | 649 | 505 | 487 | 463 | 440 | 433 | 340 | 323 | 322 | 243 |
Shares Outstanding | 0% | 66.00 | 66.00 | 66.00 | 66.00 | 66.00 | 65.00 | 66.00 | 65.00 | 61.00 | 59.00 | 57.00 | 53.00 | - | - | - | - | - | - | - | - | - |
Minority Interest | 0.1% | 22.00 | 22.00 | 22.00 | 16.00 | 16.00 | 16.00 | 15.00 | 15.00 | 15.00 | 15.00 | 14.00 | 14.00 | 13.00 | 15.00 | 15.00 | 23.00 | 30.00 | 30.00 | 30.00 | 30.00 | 30.00 |
Float | - | - | - | 564 | - | - | - | 693 | - | - | - | 892 | - | - | - | 481 | - | - | - | 324 | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Cashflow From Operations | 8.8% | 18,125 | 16,666 | 17,878 | 15,771 | 18,308 | 18,314 | 23,483 | 16,436 | 17,283 | 18,608 | 17,789 | 15,287 | 16,131 | -5,479 | 11,608 | 12,260 | 9,746 | 10,017 | 10,516 | 6,148 | 5,734 |
Share Based Compensation | 3.1% | 1,222 | 1,185 | 1,147 | 688 | 1,066 | 1,039 | 1,289 | 1,287 | 1,242 | 1,241 | 1,612 | 1,715 | 1,928 | 1,572 | 897 | 922 | 843 | 868 | 854 | 771 | 693 |
Cashflow From Investing | -155.0% | -3,114 | 5,664 | 61,974 | 3,092 | -1,410 | -33,448 | -75,798 | -26,596 | -27,925 | -50,769 | -72,399 | -43,572 | -82,060 | -65,653 | -7,196 | -68,763 | -75,523 | -65,200 | -94,819 | -22,655 | -15,187 |
Cashflow From Financing | 35.1% | -15,899 | -24,503 | -84,048 | -19,337 | -16,038 | 14,529 | 58,325 | 5,591 | 11,532 | 31,660 | 55,580 | 28,932 | 69,420 | 65,057 | -7,951 | 66,194 | 67,136 | 55,137 | 86,867 | 14,972 | 10,474 |
Dividend Payments | 0.1% | 1,456 | 1,455 | 1,456 | 1,455 | 1,456 | 1,455 | 1,456 | 1,455 | 1,456 | 1,455 | 1,456 | 1,455 | 1,456 | 1,455 | - | 2,911 | 1,457 | 1,454 | 1,456 | 1,455 | 1,455 |
Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Revenue | |||
Rental revenue | $ 140,934 | $ 137,167 | $ 115,804 |
Other income | 115 | 116 | 132 |
Total revenue | 141,049 | 137,283 | 115,936 |
Expenses | |||
General and administrative | 16,853 | 16,545 | 16,453 |
Operating expenses | 28,082 | 25,188 | 15,488 |
Depreciation expense | 41,266 | 40,008 | 33,825 |
Amortization expense | 16,869 | 16,715 | 13,050 |
Interest expense | 30,893 | 25,230 | 19,696 |
Preacquisition expense | 44 | 354 | 151 |
Total expenses | 134,007 | 124,040 | 98,663 |
Income before gain on sale of investment property | 7,042 | 13,243 | 17,273 |
Gain on sale of investment property | 15,560 | 6,753 | 1,069 |
Loss on extinguishment of debt | (868) | 0 | 0 |
Net income | 21,734 | 19,996 | 18,342 |
Less: Preferred stock dividends | (5,822) | (5,822) | (5,822) |
Less: Net income attributable to noncontrolling interest | (1,122) | (854) | (720) |
Net income (loss) attributable to common stockholders | $ 14,790 | $ 13,320 | $ 11,800 |
Net income (loss) attributable to common stockholders per share - basic | $ 0.23 | $ 0.20 | $ 0.19 |
Net income (loss) attributable to common stockholders per share - diluted | $ 0.23 | $ 0.20 | $ 0.19 |
Weighted average shares outstanding - basic | 65,550 | 65,462 | 60,640 |
Weighted average shares outstanding - diluted | 65,550 | 65,462 | 60,640 |
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Investment in real estate: | ||
Land | $ 164,315 | $ 168,308 |
Building | 1,035,705 | 1,079,781 |
Site improvements | 21,974 | 22,024 |
Tenant improvements | 66,358 | 65,987 |
Acquired lease intangible assets | 138,617 | 148,077 |
Investment in real estate, Total | 1,426,969 | 1,484,177 |
Less: accumulated depreciation and amortization | (247,503) | (198,218) |
Investment in real estate, net | 1,179,466 | 1,285,959 |
Cash and cash equivalents | 1,278 | 4,016 |
Restricted cash | 5,446 | 10,439 |
Tenant receivables, net | 6,762 | 8,040 |
Escrow deposits | 673 | 7,833 |
Deferred assets | 27,132 | 29,616 |
Derivative asset | 25,125 | 34,705 |
Goodwill | 5,903 | 5,903 |
Other Assets | 15,722 | 6,550 |
Total assets | 1,267,700 | 1,393,261 |
Liabilities: | ||
Credit Facility, net of unamortized debt issuance costs of $7,067 and $9,253 at December 31, 2023 and December 31, 2022, respectively | 585,333 | 636,447 |
Notes payable, net of unamortized debt issuance costs of $66 and $452 at December 31, 2023 and December 31, 2022, respectively | 25,899 | 57,672 |
Accounts payable and accrued expenses | 12,781 | 13,819 |
Dividends payable | 16,134 | 15,821 |
Security deposits | 3,688 | 5,461 |
Other liabilities | 12,770 | 7,363 |
Acquired lease intangible liability, net | 5,281 | 7,613 |
Total liabilities | 661,886 | 744,196 |
Commitments and Contingencies | ||
Equity: | ||
Preferred stock, $0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at December 31, 2023 and December 31, 2022, respectively (liquidation preference of $77,625 at December 31, 2023 and December 31, 2022, respectively) | 74,959 | 74,959 |
Common stock, $0.001 par value, 500,000 shares authorized; 65,565 shares and 65,518 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively | 66 | 66 |
Additional paid-in capital | 722,418 | 721,991 |
Accumulated deficit | (238,984) | (198,706) |
Accumulated other comprehensive income (loss) | 25,125 | 34,674 |
Total Global Medical REIT Inc. stockholders' equity | 583,584 | 632,984 |
Noncontrolling interest | 22,230 | 16,081 |
Total equity | 605,814 | 649,065 |
Total liabilities and equity | 1,267,700 | 1,393,261 |
Related Party [Member] | ||
Investment in real estate: | ||
Due from related parties | 193 | 200 |
Liabilities: | ||
Other liabilities | $ 0 | $ 0 |